USES OF NGAL-BINDING SUBSTANCES IN THE DIAGNOSIS AND TREATMENT OF CANCER DISEASES

Details for Australian Patent Application No. 2003245858 (hide)

Owner METAGEN PHARMACEUTICALS GMBH

Inventors HERBERTH, Gunda; DAHL, Edgar

Pub. Number AU-A-2003245858

PCT Number PCT/DE03/01986

PCT Pub. Number WO2004/005540

Priority 102 30 631.1 02.07.02 DE

Filing date 12 June 2003

Wipo publication date 23 January 2004

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 035/00 Antineoplastic agents

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

25 September 2003 Complete Application Filed

  Priority application(s): 102 30 631.1 02.07.02 DE

11 March 2004 Application Open to Public Inspection

  Published as AU-A-2003245858

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003245859-PEELING-FORMULIERUNG

2003245857-DEVICE AND METHOD FOR THE DEFLECTION OF A LASER BEAM FOR OPTICAL MEASURING SYSTEMS